ABSTRACT AIM: The aim of our prospective study was to evaluate the development of postpartum anal incontinence in patients with infl ammatory bowel disease (IBD) compared to healthy women. MATERIAL AND METHODS: Patients with IBD and healthy controls enrolled in the study from January 1st 2013 to November 30th 2016 and fi lled in the anal incontinence questionnaire in the beginning of pregnancy and after vaginal delivery. The results were statistically processed using suitable tests. RESULTS: A total of 57 women were enrolled, 17 (29.8 %) with ulcerative colitis, 23 (40.4 %) with Crohn's disease, and 17 (29.8 %) healthy controls. Incidence of postpartum anal incontinence is comparable across all groups; there was no statistically signifi cant difference between the IBD and control groups (Kruskal-Wallis test by ranks with Dunn correction, non-signifi cant). Postpartum anal incontinence was strongly correlated with the extent of perineal injury (r = 0.80; p < 0.0001; Pearson's linear correlation). CONCLUSIONS: Women with infl ammatory bowel disease in remission do not exhibit higher incidence of postpartum anal incontinence (PPAI) compared to healthy controls; the key correlate of PPAI appears to be the extent of obstetric injury, consistently across all study groups. These results suggest that concerns about postpartum anal incontinence development should not be an indication for Caesarean section in IBD patients (Tab. 6, Fig. 1, Ref. 34). Text in PDF www.elis.sk.
Introduction
Infl ammatory bowel disease (IBD) is an idiopathic condition taking the form of either Crohn's disease (CD) or ulcerative colitis (UC). It is a chronic bowel disease affecting particularly young people in reproductive age. Young women with IBD are understandably interested in how their primary disease may affect their fertility and course of pregnancy, as well as in the effects of pregnancy on their condition. Common are concerns about the development of the fetus, the method of childbirth, and the possibility of breastfeeding. Even at present, voluntary childlessness based on concerns about pregnancy and childbirth is not uncommon among IBD patients as these are often unfoundedly presented as potentially dangerous for the primary condition (1, 2) . There is a large number of studies investigating the impact of IBD and related medication on pregnancy and the fetus, as well as the impact of pregnancy and childbirth on the course of IBD (3) (4) (5) (6) (7) . An open question is childbirth care for IBD patients, especially concerning the risk of development of post-delivery anorectal dysfunction or de novo perianal disease. The impact of the delivery method chosen on sphincter function and perianal complications remains unclear, both in women with pre-existent perianal disease adjuvant to Crohn's, and in women with ulcerative colitis. There are currently no clinically-relevant guidelines for childbirth in women suffering from IBD. The ECCO (European Crohn's and Colitis Organization) guidelines list as an unambiguous gastroenterological indication for Caesarean section (CS) the presence of active perianal disease or active IBD affecting the rectum. Relative indications for elective CS are IPAA (ileal pouch-anal anastomosis) and the presence of ileorectal anastomosis in women who had undergone colectomy (7) .
Anal incontinence (AI), or fecal incontinence (FI), is defi ned as the involuntary and repeated leakage, of varying severity and frequency, of fecal material or fl atus from the anal canal with a possible impact on the patient's quality of life (8-10). The average incidence of fecal incontinence in the general population is about 8 % (11). In IBD patients, this is higher than in the general population, standing at about 10%; this includes patients currently in the quiescent phase of the disease (10). Questionnaires on AI or FI track the parameters mentioned above, including information on the need to use anti-diarrhea medication and incontinence aids and the presence of an urge to defecate (12, 13) . In the general population childbirth is one of the most frequent causes of postpartum AI or FI, especially in the case of vaginal birth with injury to the anal sphincter (10, (14) (15) (16) . Statistically signifi cant increases in the incidence of postpartum anal incontinence have been observed in patients who underwent episiotomy or had thirdor fourth-degree injuries from vaginal birth (9, 17, 18) . The risks of development of FI in IBD in patients after vaginal birth have so far been explored only in a small number of studies, with varying results. A large study in the United Kingdom did not show any impact of vaginal delivery on the development of FI in IBD patients (10) . Another, smaller study reported different results, fi nding a statistically signifi cant increase in the risk of FI development in the postpartum period in Crohn's disease patients after vaginal delivery compared to healthy controls (19) . Episiotomy should not be performed in IBD patients if possible from an obstetrics point of view, as there is risk of perianal complications, particularly in CD patients. Nonetheless, episiotomy is still preferred to uncontrolled perineal injury in childbirth (7, 20) . The objective of the prospective study presented in this paper was to determine whether IBD patients have higher incidence of anal incontinence after vaginal delivery compared to healthy controls.
Materials and methods
The present prospective comparative study investigated the risk of AI development in patients with IBD compared to healthy controls. The host institution's ethics committee approved the study and all enrolled patients have given their informed consent to participation. The study ran from January 1, 2013, and November 30, 2016; during this period, we enrolled all pregnant IBD patients from a tertiary care center; healthy controls were recruited in gynecological clinics and practices throughout the Pilsen and Karlsbad (Karlovy Vary) regions of Czech Republic. The enrollment criteria for the IBD group were: female, aged 18-40, IBD in remission, without recent perianal or rectal disease. Exclusion criteria included active IBD, active perianal disease, ileal pouchanal anastomosis (IPAA), and the presence of ileo-or colostomy. Patients were approached with the offer to be enrolled in the early stages of pregnancy, no later than the 6th week of gestation. Once patients gave their consent, inclusion and exclusion criteria were evaluated and an initial screening to evaluate IBD activity was performed. At this time all participants fi lled in an entry St. Mark's Anal Incontinence Questionnaire to evaluate their continence before pregnancy. IBD phenotype was determined using the Montreal Classifi cation (chart). Ulcerative colitis activity was evaluated using a partial Mayo Score including the frequency of defecation, scope of bleeding, and examining physician's assessment (Physical Global Assessment, PGA) (Tab. 1). Crohn's disease activity was evaluated using a simple Harvey-Bradshaw Index including the overall condition of the patient, frequency of defecation, presence of abdominal pain, fi nding of resistance in the abdominal cavity, and presence of complications outside the bowel (Tab. 2). All participants with IBD were screened every 6 UC remission is defi ned as a score of < 1.
Tab. 1. Ulcerative colitis activity based on Mayo sub-score.
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weeks for the duration of their pregnancy to assess their overall condition and potential IBD activity. The delivery method, use of episiotomy, and the presence of any childbirth-related injury were evaluated by the obstetrician performing the delivery and recorded in the delivery record. 6 weeks after delivery, all IBD and healthy patients again fi lled in a St. Mark's Anal Incontinence Questionnaire, with questions concerning incontinence in the form of fl atus or liquid or solid stool, the need to use pads for fecal incontinence, the need to use anti-diarrhea medication, and the presence of an urge to defecate, including information on the frequency of problems and impact on the patient's lifestyle (Tab. 3) (24) .
Statistical analysis
Results were statistically evaluated using the analysis of variance (ANOVA) method, Fischer's exact test, and the KruskallWallis test by ranks (post hoc analysis using Bonferroni corrections). The threshold for statistical signifi cance was set at p < 0.05. The linear correlation of the St. Mark's Incontinence Score with delivery-related injury was estimated using Pearson's correlation coeffi cient.
Results
The total study population between 2013 and 2016 was 57 women, whereof 17 (29.8 %) were diagnosed with ulcerative colitis, 23 (40.4 %) with Crohn's disease, and 17 (29.8 %) were healthy and served as the control group. All IBD patients were in remission at the time of enrollment, as evaluated by a partial Mayo Score for the UC group and the Harvey-Bradshaw Index for the CD group. During the follow-up period, one UC patient showed moderate disease activity in the 16th week of gestation; this was addressed by increasing the dosage of mesalazine and the addition of topical corticosteroids to the treatment regimen; remission was re-established by the 21st week of gestation. The patient remained in UC remission through the end of gestation and post-delivery, allowing her to remain in the study without affecting the validity of results. IBD phenotype was determined using the Montreal Classifi cation for all enrolled patients. In the UC group, 15 out of the total of 17 patients (88 %) had the extensive (E3) form of the disease; the remaining 2 patients (12 %) in this group had the left-sided (or distal) (E2) form. In the CD group the disease was predominantly ileocecal (14 out of 23; 60.8 %), with the remainder affecting the colon (9 out of 23; 39.2 %). Four of the patients whose CD affected the colon were also diagnosed with perianal disease. 9 out of the total of 40 IBD patients (22 %) had fi rst diagnosis of IBD before the age of 17 (A1), while in the remaining 31 (78 %), IBD had fi rst been diagnosed between the ages of 17 and 40 (A2). All IBD patients in the study had been diagnosed with the disease prior to pregnancy (Chart). The study thus consisted of three groups: a) the Crohn's disease group (n = 23; mean age 28.5 ± 3.9); b) the ulcerative colitis group (n = 17; mean age 30.71 ± 4.24); and c) the volunteer healthy control group (n = 17; mean age 28.00 ± 3.93). Monitored factors included the type of delivery (vaginal vs. Caesarean section), the degree of perineal injury in childbirth (none to 4th-degree), and the need to perform episiotomy. All patients also fi lled in the St. Mark's Anal Incontinence Questionnaire at the start of pregnancy (i.e., equivalent to pre-pregnancy state), and again after delivery. The UC group had signifi cantly higher incidence of Caesarean section births than the healthy control group (p < 0.05); for the CD group the signifi cance for this indicator was marginal (p = 0.06). The incidence of postpartum complications and frequency of episiotomy were, on the other hand, not signifi cantly different across the three groups. A summary of these results is given in Table 4. The assessment of the overall results of the early pregnancy questionnaire survey revealed a statistically signifi cant difference between the CD group and the healthy control (p < 0.05). On an item-by-item basis, the differences were concentrated in questions regarding lifestyle changes and the use of hygiene aids for fecal incontinence. However, there were no statistically signifi cant differences found in the assessment of the post-delivery survey. According to our results, a CD or UC diagnosis has no impact on the risk of development of postpartum anal incontinence (detailed results are shown in Tables 5 and 6 ). However, our results do indicate a signifi cant correlation of the postpartum St. Mark's Score and the extent of delivery-related injury (Pearson's correlation coeffi cient r = 0.80; p < 0.0001).
Discussion
Crohn's disease and ulcerative colitis commonly affect young, reproductive age people. There is a large number of studies investigating the impact of infl ammatory bowel disease and related medication on pregnancy and the fetus, and vice versa, the effects of pregnancy and childbirth on the course of IBD. An open question of considerable clinical signifi cance is the optimal method of delivery in IBD patients with regards to possible sphincter injury and its impact on current and future bowel function (7) . One of the unclear issues is the impact of childbirth on the development of postpartum incontinence in IBD patients; there is a need to investigate the effects of vaginal delivery on sphincter function, as well as on the development of perianal complications in patients with pre-existing perianal disease adjuvant to Crohn's and in patients with ulcerative colitis. In the last 20 years, statistics show an increase in the prevalence of Caesarean section births (19, (25) (26) (27) . Prior studies have demonstrated a higher incidence of Caesarean section births in IBD patients compared to the general population (28, 29) ; this is also seen in our results, where the number of CS births was signifi cantly higher in IBD patients compared to healthy controls. From a gastroenterological standpoint, a clear indication for CS is the presence of active perianal disease or active IBD affecting the rectum; relative indications for elective SC include IPAA (ileal pouch-anal anastomosis) and ileorectal anastomosis in patients who had undergone colectomy for refractory UC. Nonetheless, the decision about the method of delivery should ultimately be made based on obstetric factors.
Anal or fecal incontinence is defi ned as the involuntary and repeated leakage of fecal material or fl atus from the anal canal; severity varies from occasional leaks of fecal material when passing fl atus to complete loss of fecal continence. It is a stressful and serious condition with a signifi cant impact on the patient's quality of life, affecting professional, social, and sexual activities (8) (9) (10) . The incidence of fecal incontinence in the general population is around 8%; however, the distribution is age-asymmetric: In the age group from 20 to 29, FI prevalence in the general population is only about 3 %, increasing to 17 % in those aged over 70 (11) . An extensive questionnaire survey of IBD patients revealed that up to 74 % of IBD patients experience AI or FI symptoms at least once (10). The incidence of FI in IBD patients is higher than in the general population, standing at about 10 %, including patients in the quiescent phase of the disease (10) . Our study demonstrated a signifi cantly higher incidence of AI in female Crohn's patients before pregnancy. This may be explained by a colon-affecting CD phenotype combined with perianal disease; although all CD patients in our study were in remission, the localization of the disease may have played a role in the increased incidence of FI. There is currently a lack of consensus in the academic community as to whether the defi nition of fecal incontinence should also include the involuntary leakage of intestinal gas, or whether it should be limited to the involuntary leakage of liquid and solid stool. However, most authors prefer to exclude intestinal gas from their defi nition of FI, as fl atus leakage is experienced also by a high percentage of healthy individuals. Fecal incontinence surveys track all the mentioned parameters, including the need to take anti-diarrhea medication and use incontinence aids and the presence of an urge to defecate (12, 13) . As a rule, the term fecal incontinence is used only for the leakage of stool of varying consistency, while the definition of anal incontinence additionally also includes the leakage of intestinal gas from the anal canal (30). Patient surveys have shown that patients consider intestinal gas leaks to be an important sign of incontinence with a signifi cant impact on quality of life that should be included in the defi nition of FI (31, 32). In our study as well, all patients who listed involuntary fl atus leaks in the questionnaire also indicated the necessity of lifestyle changes on their part and lower quality of life in general. Many scoring systems for the severity of anal incontinence exist, of varying quality. The currently most commonly-used anal incontinence questionnaire is the Wexner Score; however, in this paper we preferred to use St. Mark's Fecal Incontinence Score, as defi ned in 1999, to determine the severity of anal incontinence (24) . We have chosen this particular method because it surveys not only fecal incontinence in the narrow sense, but also touches on wider issues in anal incontinence with questions on involuntary fl atus leakage, the need to use incontinence aids and anti-diarrhea medication, and impacts on patients' quality of life (13, 24) . Childbirth is one of the principal causes of anal and fecal incontinence in the general female population, particularly in the case of vaginal delivery with injury to the anal sphincter (obstetric anal sphincter injury, or OASIS). Midline episiotomy for vaginal delivery signifi cantly increases the risk of postpartum FI development compared to vaginal delivery with an intact perineum. Mediolateral episiotomy, even with known sphincter injury (OASIS), appears to be protective against postpartum FI development (15, 33, 34). The severity of childbirth perineal injury according to perineal rupture classifi cation is defi ned as: 1st degree -injury to skin and hypodermis of the perineum and the vaginal mucosa; 2nd degree -with rupture of pelvic diaphragm muscles; 3rd degree -with injury to external anal sphincter (EAS) and internal anal sphincter (IAS); 4th degree -with injury to anal sphincter complex and rectal mucosa (9, 17, 34) . The results of studies on the risk of AI development due to episiotomy and obstetric perineal injury are not completely consistent; however, a recent meta-analysis shows that both episiotomy and 3rd-4th-degree obstetric perineal injury are associated with higher incidence of postpartum AI or FI (9) . The risks of FI development in IBD patients have, so far, been only rarely investigated. A large study in the United Kingdom did not show increased risk of FI development in vaginal delivery in IBD patients (10) . Different results are presented in a study by Ong, which shows a statistically signifi cant increase in risk of postpartum FI development in CD patients after vaginal delivery compared to healthy controls (19) . Episiotomy, if obstetrically possible to avoid, is not recommended for IBD patients due to risk of perianal complications; however, it is still preferred to uncontrolled obstetric perineal injury (7, 20) . Vaginal delivery in IBD patients is not associated with an increased risk of perianal disease compared to CS (7, 22, 23) . The study presented in this paper did not show a statistically signifi cant difference in the incidence of obstetric perineal injury and the frequency of episiotomy across our study groups. Our results suggest that a diagnosis of CD or UC does not increase the risk of postpartum AI development; however, we did fi nd a signifi cant positive correlation between the post-delivery St. Mark's Incontinence Score and the extent of perineal injury (Pearson's correlation coeffi cient r = 0.80; p < 0.0001).
There is a need for more prospective studies on the relationship of IBD, type of delivery, and development of postpartum AI or FI. These studies should objectively evaluate potential postpartum anorectal dysfunction using manometry or sphincter injury assessment with endoanal ultrasonography or dynamic MRI (10, 19) .
Conclusion
The incidence of postpartum anal or fecal incontinence symptoms in patients with IBD is comparable to healthy controls. Postpartum AI or FI incidence is positively correlated with the extent of obstetric injury among IBD patients and the general population. IBD does not appear to be a risk factor for the development of postpartum AI in vaginal delivery; therefore, concerns about the development of postpartum AI should not be a strict indication for Caesarean section in patients with a diagnosis of ulcerative colitis or Crohn's disease. The decision about the method of delivery should, aside from specifi c indications related directly to IBD, be made primarily on the basis of obstetric factors.
